Thus, although PMCA2 was shown to be more resistant to amyloid-β inhibition, its downregulation in the aging brain, together with lowered PMCA4 activity and the CaM amount, could be responsible for progressive development of AD symptoms. The gene discussed is ATP2B4; the disease is Alzheimer disease.